Jeffrey L Sturchio
Biographic Data
| ID | 389003 |
|---|---|
| NAME | Jeffrey L Sturchio |
| GIVEN NAMES | Jeffrey L |
| FAMILY NAME | Sturchio |
| SIGNATURE | STURCHIO J L |
| AFFILIATIONS | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| ORCID | 0000-0002-0108-0167 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 17 |
| AUTHOR COUNT | 13 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1980 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 1 |
Integrating Social Determinants in Decision-Making Processes for Health
Improving Decision-Making for Population Health in Nonhealth Sectors in Urban Environments
Opinions
No available abstract
Pharmaceutical Firms and the Transition to Biotechnology
During the twentieth century, the pharmaceutical industry experienced a series of dramatic changes as developments in science and technology generated new opportunities for innovation. Each of these transitions forced existing firms to develop new capabilities. The authors examine the most recent such transition, the shift to molecular genetics and recombinant DNA technology (1970 to the present), and explain how and why this transformation diffe…
Evolutionary Innovations
Evolutionary Innovations
332 Book Reviews TECHNOLOGY AND CULTURE other and at themselves” (p. 297). Some historians of science and technology might express concern with this tidy origin story. Thomas Kuhn, for instance, used the ambiguity of Roentgen’s “dis covery”—8 November 1895? 22 December 1895? 5 January 1896?— to illustrate the difficulty of singling out revolutionary individuals or moments. One might also raise further questions regarding issues of socialjustice …
The pharmaceutical industry in the twentieth century
The authors use an historical case‐study of a single line of therapeutic development (in vaccines and serum antitoxins) to bring out salient aspects of the shifting sources of innovation in the pharmaceutical industry during the twentieth century. Their emphasis is on the complex relationships that have evolved between three companies ‐ Mulford, Sharp & Dohme, and Merck & Co., Inc. ‐ and the loosely integrated networks of public, profit‐making, a…
Ambix. Journal of the Society for the History of Alchemy and Chemistry . Michael A. Sutton
Chemistry in America, 1876-1976
"Introduction To Science and Technology Studies"
La introducción de la nueva nomenclatura química y el rechazo de la teoría de la acidez de Lavoisier en España
Classics in Coordination Chemistry. Part III
Philosophical Chemistry in the Scottish Enlightenment
Pharmaceutical Firms and the Transition to Biotechnology
During the twentieth century, the pharmaceutical industry experienced a series of dramatic changes as developments in science and technology generated new opportunities for innovation. Each of these transitions forced existing firms to develop new capabilities. The authors examine the most recent such transition, the shift to molecular genetics and recombinant DNA technology (1970 to the present), and explain how and why this transformation diffe…
Opinions
No available abstract
Classics in Coordination Chemistry. Part III
Philosophical Chemistry in the Scottish Enlightenment
La introducción de la nueva nomenclatura química y el rechazo de la teoría de la acidez de Lavoisier en España
"Introduction To Science and Technology Studies"
Chemistry in America, 1876-1976
Ambix. Journal of the Society for the History of Alchemy and Chemistry . Michael A. Sutton
The pharmaceutical industry in the twentieth century
The authors use an historical case‐study of a single line of therapeutic development (in vaccines and serum antitoxins) to bring out salient aspects of the shifting sources of innovation in the pharmaceutical industry during the twentieth century. Their emphasis is on the complex relationships that have evolved between three companies ‐ Mulford, Sharp & Dohme, and Merck & Co., Inc. ‐ and the loosely integrated networks of public, profit‐making, a…
Pharmaceutical Firms and the Transition to Biotechnology
During the twentieth century, the pharmaceutical industry experienced a series of dramatic changes as developments in science and technology generated new opportunities for innovation. Each of these transitions forced existing firms to develop new capabilities. The authors examine the most recent such transition, the shift to molecular genetics and recombinant DNA technology (1970 to the present), and explain how and why this transformation diffe…
Evolutionary Innovations
Evolutionary Innovations
332 Book Reviews TECHNOLOGY AND CULTURE other and at themselves” (p. 297). Some historians of science and technology might express concern with this tidy origin story. Thomas Kuhn, for instance, used the ambiguity of Roentgen’s “dis covery”—8 November 1895? 22 December 1895? 5 January 1896?— to illustrate the difficulty of singling out revolutionary individuals or moments. One might also raise further questions regarding issues of socialjustice …
Opinions
No available abstract
Integrating Social Determinants in Decision-Making Processes for Health
Improving Decision-Making for Population Health in Nonhealth Sectors in Urban Environments
Engineering (4 works) · History (4 works) · Philosophy (4 works) · Sociology (4 works) · Art history (3 works) · Biotechnology and Related Fields (3 works) · Business (3 works) · Computer Science (3 works) · Epistemology (3 works) · History and advancements in chemistry (3 works)